Reference : Hematopoietic cell transplantation after reduced-intensity conditioning for older adults...
Scientific journals : Article
Human health sciences : Hematology
http://hdl.handle.net/2268/22915
Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission
English
Baron, Frédéric mailto [Université de Liège - ULg > Département des sciences cliniques > Hématologie]
Storb, R. [> > > >]
Mar-2007
Current Opinion in Hematology
Lippincott Williams & Wilkins
14
2
145-151
Yes (verified by ORBi)
International
1065-6251
Philadelphia
[en] acute myeloid leukemia ; graft-versus-tumor effect ; hematopoietic stem cell transplantation ; nonmyeloablative ; reduced-intensity conditioning
[en] Purpose of review Allogeneic hematopoietic cell transplantation with myeloablative conditioning is a well established therapy for patients with acute myeloid leukemia. Its efficacy depends, in part, on the destruction of recipient acute myeloid leukemia cells by the conditioning regimen and, in part on their removal by donor immune cells contained in the graft (graft-versus-tumor effect). Due to regiment related toxicities, the use of myeloablative allogeneic hematopoietic cell transplantation has been restricted to younger patients in good condition. More recently, the introduction of allogeneic hematopoietic cell transplantation following reduced-intensity or nonmyeloablative conditioning regimens, which rely mainly on graft-versus-tumor effects for tumor cell eradication, has permitted extending hematopoietic cell transplantation to include older patients and those with medical comorbidities. Recent findings Early results with allogeneic hematopoietic cell transplantation after nonmyeloablative and reduced-intensity conditioning for patients with acute myeloid leukemia in first complete remission are encouraging, with 2-year survivals after hematopoietic cell transplantation ranging from 48 to 79% among studies. Further, retrospective studies have demonstrated similar outcomes in adult patients with acute myeloid leukemia in complete remission given either myeloablative or nonmyeloablative conditioning. Summary Prospective studies are needed to define the place of allogeneic hematopoietic cell transplantation after nonmyeloablative or reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission, and to determine a role for consolidation chemotherapy before hematopoietic cell transplantation, if any.
http://hdl.handle.net/2268/22915
10.1097/MOH.0b013e3280168462

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
BaronStorbRicAMLCOH07.pdfPublisher postprint129.65 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.